Cargando…
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
Over the past two decades, the viewpoint of atherosclerosis has been replaced gradually by a lipid-driven, chronic, low-grade inflammatory disease of the arterial wall. Current treatment of atherosclerosis is focused on limiting its risk factors, such as hyperlipidemia or hypertension. However, trea...
Autores principales: | Li, Bin, Li, Weihong, Li, Xiaoli, Zhou, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302344/ https://www.ncbi.nlm.nih.gov/pubmed/28034355 http://dx.doi.org/10.2174/1381612822666161230142931 |
Ejemplares similares
-
Inflammation as a Therapeutic Target in Atherosclerosis
por: Nguyen, Mau T, et al.
Publicado: (2019) -
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
por: Engelen, Suzanne E., et al.
Publicado: (2022) -
Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis
por: Nguyen, Tien K., et al.
Publicado: (2022) -
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
por: Stojanović, Stevan D, et al.
Publicado: (2020) -
The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy
por: Lu, Yongzheng, et al.
Publicado: (2022)